Enhanced Target Binding by Leritrelvir Restores Dimerization of Mpro Mutants and Mitigates Drug Resistance
This study demonstrates that the antiviral drug leritrelvir effectively overcomes resistance to nirmatrelvir by restoring the dimerization of SARS-CoV-2 main protease mutants through tighter binding, thereby maintaining superior inhibitory and cellular antiviral efficacy against resistant variants.